Review



emerin expression  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Proteintech emerin expression
    Emerin Expression, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 45 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emerin+expression/Emerin+Antibody/pm41275856-38-2-15
    Average 94 stars, based on 45 article reviews
    emerin expression - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.
    Article Snippet: .. Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. (A) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). ..

    Article Title: Emerin expression stratification across breast cancer subtypes
    Article Snippet: .. We analyzed emerin expression on 86 additional patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (BR804b and BR480b, TissueArray, LLC) to increase the power of our studies. ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. Fig. 9 Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. ( A ) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). ..

    Article Title: Emerin expression stratification across breast cancer subtypes.
    Article Snippet: .. We analyzed emerin expression on 86 additional patient samples by immunohistochemistry with emerin antibodies (10351–1-AP, Proteintech) on a tissue microarray (BR804b and BR480b, TissueArray, LLC) to increase the power of our studies. ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Microarray:

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.
    Article Snippet: .. Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. (A) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). ..

    Article Title: Emerin expression stratification across breast cancer subtypes
    Article Snippet: .. We analyzed emerin expression on 86 additional patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (BR804b and BR480b, TissueArray, LLC) to increase the power of our studies. ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. Fig. 9 Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. ( A ) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). ..

    Article Title: Emerin expression stratification across breast cancer subtypes.
    Article Snippet: .. We analyzed emerin expression on 86 additional patient samples by immunohistochemistry with emerin antibodies (10351–1-AP, Proteintech) on a tissue microarray (BR804b and BR480b, TissueArray, LLC) to increase the power of our studies. ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Staining:

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.
    Article Snippet: .. Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. (A) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. Fig. 9 Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. ( A ) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). ..

    Immunohistochemistry:

    Article Title: Emerin expression stratification across breast cancer subtypes
    Article Snippet: .. We analyzed emerin expression on 86 additional patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (BR804b and BR480b, TissueArray, LLC) to increase the power of our studies. ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..

    Article Title: Emerin expression stratification across breast cancer subtypes.
    Article Snippet: .. We analyzed emerin expression on 86 additional patient samples by immunohistochemistry with emerin antibodies (10351–1-AP, Proteintech) on a tissue microarray (BR804b and BR480b, TissueArray, LLC) to increase the power of our studies. ..

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype
    Article Snippet: .. To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC). ..



    Similar Products

    emerin expression  (Proteintech)
    94
    Proteintech emerin expression
    Emerin Expression, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emerin+expression/Emerin+Antibody/pm41275856-38-2-15
    Average 94 stars, based on 1 article reviews
    emerin expression - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    emerin protein expression  (Proteintech)
    94
    Proteintech emerin protein expression
    Fig. 1. <t>Emerin</t> <t>protein</t> expression in MCF7, scrambled shRNA, and MCF7 emerin shRNA-transfected cell lines. (A) Representative western blot and (B) quantification of MCF7, scrambled shRNA, and three emerin shRNA cell lines normalized to γ-tubulin. *P = 0.0108, **P = 0.0061, N = 10–13, One-way ANOVA followed by Dunnett’s multiple comparison.
    Emerin Protein Expression, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emerin+expression/Emerin+Antibody/pm39198511-95-4-28
    Average 94 stars, based on 1 article reviews
    emerin protein expression - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 1. Emerin protein expression in MCF7, scrambled shRNA, and MCF7 emerin shRNA-transfected cell lines. (A) Representative western blot and (B) quantification of MCF7, scrambled shRNA, and three emerin shRNA cell lines normalized to γ-tubulin. *P = 0.0108, **P = 0.0061, N = 10–13, One-way ANOVA followed by Dunnett’s multiple comparison.

    Journal: Scientific reports

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.

    doi: 10.1038/s41598-024-70752-5

    Figure Lengend Snippet: Fig. 1. Emerin protein expression in MCF7, scrambled shRNA, and MCF7 emerin shRNA-transfected cell lines. (A) Representative western blot and (B) quantification of MCF7, scrambled shRNA, and three emerin shRNA cell lines normalized to γ-tubulin. *P = 0.0108, **P = 0.0061, N = 10–13, One-way ANOVA followed by Dunnett’s multiple comparison.

    Article Snippet: To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC).

    Techniques: Expressing, shRNA, Transfection, Western Blot, Comparison

    Fig. 9. Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. (A) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). Nuclei are blue, emerin is brown, and arrows denote emerin staining in certain images for reference. As severity of cases increases, there is a visible reduction in emerin expression at the nuclear envelope and more deformed nuclei are present. (B) Quantification of emerin staining on IHC-stained patient samples using 0–3, with 0 having no staining at the nuclear periphery and 3 having complete, dark rim staining. N = 159 total samples, *P < 0.05 compared to normal tissue, one-way ANOVA and Dunnett’s test. Error bars represent standard deviation. (C) Representative tissue microarray staining of emerin in 183 patients using emerin monoclonal antibodies (Leica, NCL-Emerin) or secondary alone (Vector Lab, cat#: MP-7452) using the same samples used in A. Nuclei are blue and emerin is brown. As aggressiveness of cases increases, there is a visible reduction in emerin expression and more deformed nuclei are present. (D) Quantification of emerin staining using the 0 to 3 grading system. N = 183 total samples #P < 0.02 compared to all non-cancerous tissue, *P < 0.0062 compared to both normal and benign tissue, one-way ANOVA and Dunnett’s test. Error bars represent standard deviation.

    Journal: Scientific reports

    Article Title: Emerin deficiency drives MCF7 cells to an invasive phenotype.

    doi: 10.1038/s41598-024-70752-5

    Figure Lengend Snippet: Fig. 9. Reduced emerin expression at the nuclear periphery correlates with breast cancer invasiveness in patients. (A) Representative tissue microarray staining of emerin in 159 patients using emerin polyclonal antibodies (Proteintech, cat# 10351-1-AP) or secondary alone (Vector Lab, cat#: MP-7451). Nuclei are blue, emerin is brown, and arrows denote emerin staining in certain images for reference. As severity of cases increases, there is a visible reduction in emerin expression at the nuclear envelope and more deformed nuclei are present. (B) Quantification of emerin staining on IHC-stained patient samples using 0–3, with 0 having no staining at the nuclear periphery and 3 having complete, dark rim staining. N = 159 total samples, *P < 0.05 compared to normal tissue, one-way ANOVA and Dunnett’s test. Error bars represent standard deviation. (C) Representative tissue microarray staining of emerin in 183 patients using emerin monoclonal antibodies (Leica, NCL-Emerin) or secondary alone (Vector Lab, cat#: MP-7452) using the same samples used in A. Nuclei are blue and emerin is brown. As aggressiveness of cases increases, there is a visible reduction in emerin expression and more deformed nuclei are present. (D) Quantification of emerin staining using the 0 to 3 grading system. N = 183 total samples #P < 0.02 compared to all non-cancerous tissue, *P < 0.0062 compared to both normal and benign tissue, one-way ANOVA and Dunnett’s test. Error bars represent standard deviation.

    Article Snippet: To rigorously determine if emerin protein expression inversely correlates with cancer invasiveness in patients, we analyzed emerin expression on 216 patient samples by immunohistochemistry with emerin antibodies (10351-1-AP, Proteintech) on a tissue microarray (TissueArray, LLC).

    Techniques: Expressing, Microarray, Staining, Plasmid Preparation, Standard Deviation, Bioprocessing